PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BLUE vs. BLIN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BLUE and BLIN is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

BLUE vs. BLIN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in bluebird bio, Inc. (BLUE) and Bridgeline Digital, Inc. (BLIN). The values are adjusted to include any dividend payments, if applicable.

-50.00%0.00%50.00%100.00%150.00%AugustSeptemberOctoberNovemberDecember2025
-63.30%
85.71%
BLUE
BLIN

Key characteristics

Sharpe Ratio

BLUE:

-0.46

BLIN:

1.60

Sortino Ratio

BLUE:

-0.31

BLIN:

2.50

Omega Ratio

BLUE:

0.96

BLIN:

1.32

Calmar Ratio

BLUE:

-0.71

BLIN:

1.24

Martin Ratio

BLUE:

-1.29

BLIN:

6.25

Ulcer Index

BLUE:

54.77%

BLIN:

19.78%

Daily Std Dev

BLUE:

151.89%

BLIN:

77.23%

Max Drawdown

BLUE:

-99.80%

BLIN:

-99.99%

Current Drawdown

BLUE:

-99.72%

BLIN:

-99.97%

Fundamentals

Market Cap

BLUE:

$81.18M

BLIN:

$18.13M

EPS

BLUE:

-$36.39

BLIN:

-$0.20

PEG Ratio

BLUE:

0.32

BLIN:

0.00

Total Revenue (TTM)

BLUE:

$45.29M

BLIN:

$11.60M

Gross Profit (TTM)

BLUE:

-$21.31M

BLIN:

$7.58M

EBITDA (TTM)

BLUE:

-$99.14M

BLIN:

-$661.00K

Returns By Period

In the year-to-date period, BLUE achieves a 0.12% return, which is significantly lower than BLIN's 10.13% return. Over the past 10 years, BLUE has outperformed BLIN with an annualized return of -39.47%, while BLIN has yielded a comparatively lower -44.52% annualized return.


BLUE

YTD

0.12%

1M

-1.76%

6M

-63.38%

1Y

-67.00%

5Y*

-63.24%

10Y*

-39.47%

BLIN

YTD

10.13%

1M

16.78%

6M

80.12%

1Y

131.08%

5Y*

2.22%

10Y*

-44.52%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BLUE vs. BLIN — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BLUE
The Risk-Adjusted Performance Rank of BLUE is 1818
Overall Rank
The Sharpe Ratio Rank of BLUE is 2222
Sharpe Ratio Rank
The Sortino Ratio Rank of BLUE is 2424
Sortino Ratio Rank
The Omega Ratio Rank of BLUE is 2424
Omega Ratio Rank
The Calmar Ratio Rank of BLUE is 88
Calmar Ratio Rank
The Martin Ratio Rank of BLUE is 1111
Martin Ratio Rank

BLIN
The Risk-Adjusted Performance Rank of BLIN is 8686
Overall Rank
The Sharpe Ratio Rank of BLIN is 8888
Sharpe Ratio Rank
The Sortino Ratio Rank of BLIN is 8787
Sortino Ratio Rank
The Omega Ratio Rank of BLIN is 8585
Omega Ratio Rank
The Calmar Ratio Rank of BLIN is 8383
Calmar Ratio Rank
The Martin Ratio Rank of BLIN is 8585
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BLUE vs. BLIN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for bluebird bio, Inc. (BLUE) and Bridgeline Digital, Inc. (BLIN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BLUE, currently valued at -0.46, compared to the broader market-2.000.002.004.00-0.461.60
The chart of Sortino ratio for BLUE, currently valued at -0.31, compared to the broader market-4.00-2.000.002.004.006.00-0.312.50
The chart of Omega ratio for BLUE, currently valued at 0.96, compared to the broader market0.501.001.502.000.961.32
The chart of Calmar ratio for BLUE, currently valued at -0.71, compared to the broader market0.002.004.006.00-0.711.24
The chart of Martin ratio for BLUE, currently valued at -1.29, compared to the broader market-10.000.0010.0020.0030.00-1.296.25
BLUE
BLIN

The current BLUE Sharpe Ratio is -0.46, which is lower than the BLIN Sharpe Ratio of 1.60. The chart below compares the historical Sharpe Ratios of BLUE and BLIN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50AugustSeptemberOctoberNovemberDecember2025
-0.46
1.60
BLUE
BLIN

Dividends

BLUE vs. BLIN - Dividend Comparison

Neither BLUE nor BLIN has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BLUE vs. BLIN - Drawdown Comparison

The maximum BLUE drawdown since its inception was -99.80%, roughly equal to the maximum BLIN drawdown of -99.99%. Use the drawdown chart below to compare losses from any high point for BLUE and BLIN. For additional features, visit the drawdowns tool.


-100.00%-99.80%-99.60%-99.40%-99.20%AugustSeptemberOctoberNovemberDecember2025
-99.72%
-99.90%
BLUE
BLIN

Volatility

BLUE vs. BLIN - Volatility Comparison

The current volatility for bluebird bio, Inc. (BLUE) is 33.73%, while Bridgeline Digital, Inc. (BLIN) has a volatility of 50.76%. This indicates that BLUE experiences smaller price fluctuations and is considered to be less risky than BLIN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%AugustSeptemberOctoberNovemberDecember2025
33.73%
50.76%
BLUE
BLIN

Financials

BLUE vs. BLIN - Financials Comparison

This section allows you to compare key financial metrics between bluebird bio, Inc. and Bridgeline Digital, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab